Sterling Capital Management LLC Xeris Biopharma Holdings, Inc. Transaction History
Sterling Capital Management LLC
- $6.83 Trillion
- Q3 2025
A detailed history of Sterling Capital Management LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 372 shares of XERS stock, worth $2,697. This represents 0.0% of its overall portfolio holdings.
Number of Shares
372
Previous 362
2.76%
Holding current value
$2,697
Previous $1.69 Million
79.07%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...